1. Home
  2. HFBL vs BOLD Comparison

HFBL vs BOLD Comparison

Compare HFBL & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HFBL
  • BOLD
  • Stock Information
  • Founded
  • HFBL 1924
  • BOLD 2018
  • Country
  • HFBL United States
  • BOLD United States
  • Employees
  • HFBL N/A
  • BOLD N/A
  • Industry
  • HFBL Savings Institutions
  • BOLD
  • Sector
  • HFBL Finance
  • BOLD
  • Exchange
  • HFBL Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • HFBL 41.7M
  • BOLD 30.3M
  • IPO Year
  • HFBL N/A
  • BOLD 2024
  • Fundamental
  • Price
  • HFBL $12.76
  • BOLD $1.50
  • Analyst Decision
  • HFBL
  • BOLD Hold
  • Analyst Count
  • HFBL 0
  • BOLD 1
  • Target Price
  • HFBL N/A
  • BOLD N/A
  • AVG Volume (30 Days)
  • HFBL 3.0K
  • BOLD 63.1K
  • Earning Date
  • HFBL 05-01-2025
  • BOLD 05-16-2025
  • Dividend Yield
  • HFBL 4.08%
  • BOLD N/A
  • EPS Growth
  • HFBL N/A
  • BOLD N/A
  • EPS
  • HFBL 1.09
  • BOLD N/A
  • Revenue
  • HFBL $20,019,000.00
  • BOLD N/A
  • Revenue This Year
  • HFBL N/A
  • BOLD N/A
  • Revenue Next Year
  • HFBL N/A
  • BOLD N/A
  • P/E Ratio
  • HFBL $11.70
  • BOLD N/A
  • Revenue Growth
  • HFBL N/A
  • BOLD N/A
  • 52 Week Low
  • HFBL $10.60
  • BOLD $1.06
  • 52 Week High
  • HFBL $14.08
  • BOLD $12.26
  • Technical
  • Relative Strength Index (RSI)
  • HFBL 40.83
  • BOLD N/A
  • Support Level
  • HFBL $12.86
  • BOLD N/A
  • Resistance Level
  • HFBL $13.39
  • BOLD N/A
  • Average True Range (ATR)
  • HFBL 0.07
  • BOLD 0.00
  • MACD
  • HFBL -0.07
  • BOLD 0.00
  • Stochastic Oscillator
  • HFBL 1.22
  • BOLD 0.00

About HFBL Home Federal Bancorp Inc. of Louisiana

Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: